Learn more →
Back to Expert Scholars
melanoma / melanomaMelanoma Immunotherapy

Jeffrey Weber

杰弗里·韦伯

MD, PhD

🏢NYU Langone Perlmutter Cancer Center(纽约大学朗格尼珀尔马特癌症中心)🌐USA

Deputy Director, Professor of Medicine副主任,医学教授

88
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Jeffrey Weber is a melanoma immunotherapy leader at NYU Langone who ran pivotal early trials of ipilimumab and nivolumab. His research on neoadjuvant immunotherapy, adjuvant checkpoint blockade, and predictive biomarkers has substantially advanced the field of melanoma management.

Share:

🧪Research Fields 研究领域

Melanoma黑色素瘤
Immunotherapy Biomarkers免疫治疗生物标志物
Neoadjuvant Immunotherapy新辅助免疫治疗
Ipilimumab伊匹单抗
Adjuvant Therapy辅助治疗

🎓Key Contributions 主要贡献

Ipilimumab Clinical Development

Conducted early-phase ipilimumab trials establishing anti-CTLA-4 as the first immune checkpoint therapy to show an overall survival benefit in metastatic melanoma.

Adjuvant Nivolumab in Melanoma

Led CheckMate 238 trial demonstrating nivolumab superiority over ipilimumab as adjuvant therapy in resected stage IIIB-IV melanoma, with improved RFS and tolerability.

Immunotherapy Biomarker Research

Identified gut microbiome composition, tumor mutational burden, and immune gene expression profiles as predictors of checkpoint immunotherapy response and toxicity in melanoma.

Representative Works 代表性著作

[1]

Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma (CheckMate 238)

New England Journal of Medicine (2017)

Established nivolumab as the preferred adjuvant immunotherapy over ipilimumab in resected high-risk melanoma.

[2]

Phase I/II Study of Ipilimumab Monotherapy in Patients with Metastatic Melanoma

Journal of Clinical Oncology (2008)

Early clinical trial establishing durable antitumor activity of anti-CTLA-4 ipilimumab in advanced melanoma.

[3]

Gut Microbiome Diversity and Checkpoint Immunotherapy Response in Melanoma

Science (2018)

Demonstrated that gut microbiome composition influences response to anti-PD-1 therapy in melanoma patients.

🏆Awards & Recognition 奖项与荣誉

🏆ASCO Distinguished Scientist Award
🏆American Cancer Society Clinical Research Professor Award
🏆Society for Melanoma Research Presidential Award
🏆SITC Wayne C. Koff Leadership Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 杰弗里·韦伯 的研究动态

Follow Jeffrey Weber's research updates

留下邮箱,当我们发布与 Jeffrey Weber(NYU Langone Perlmutter Cancer Center)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment